Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990;27(3):248-50.
doi: 10.1007/BF00685722.

DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II)

L Pendyala  1 , A V Arakali, P Sansone, J W Cowens, P J Creaven
Affiliations

DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II)

L Pendyala et al. Cancer Chemother Pharmacol. 1990.

Abstract

The quadrivalent second-generation platinum complex iproplatin and an in vivo divalent metabolite of iproplatin, cis-dichloro-bis-isopropylamine platinum (CIP) were tested for binding to DNA in vitro. DNA binding was determined according to radioactivity measured using [14C]-iproplatin and [14C]-CIP and also by platinum content. Results indicate that (a) iproplatin shows negligible binding to DNA, (b) CIP binds to DNA in a time-dependent fashion, and (c) the isopropylamine ligand is intact when CIP is bound to DNA. Glutathione (GSH) inhibits the binding of CIP to DNA, possibly by inhibiting binding to DNA of the aquated form of CIP.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cancer Chemother Pharmacol. 1983;10(3):145-9 - PubMed
    1. Prog Med Chem. 1987;24:129-58 - PubMed
    1. Prog Clin Biol Res. 1986;223:115-28 - PubMed
    1. Cancer Res. 1988 Jun 15;48(12):3533-6 - PubMed
    1. Cancer Chemother Pharmacol. 1989;25(1):10-4 - PubMed

Publication types

LinkOut - more resources